4th FierceBiotech Drug Development Forum

28 - 29 October, 2019


The colonnade hotel

Boston, Massachusetts

Organized by:

ExL Events

ExL Events, Inc.

685 Third Avenue, 21st Floor, New York, NY 10017




Event Information

As many blockbuster products face the loss of exclusivity, life science organizations face staunch competition from generic and biosimilar products to maintain their stronghold in certain markets. There is a lot riding on the success of new drug development, and companies are increasingly turning to external sources of innovation to supplement organic pipeline growth and replace key products within their portfolios.


Biotechs continue to push the boundaries of R&D innovation, exploring specialized areas of research, often entering undefined, first-in-class territory. However, changing regulatory requirements, payer expectations, and investor demands make drug development and commercialization an increasingly risky endeavor, leaving little to no margin for error. It takes strong leadership, a well-articulated and communicated shared vision, and innovative partnerships to navigate the competitive landscape and ensure the successful development of a commercially viable product in today’s healthcare environment.


FierceBiotech’s 4th Drug Development Forum features executive leadership perspectives from biotech and big pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend and unlock the potential of a licensing, joint venture or M&A deal.

Venue & Direction

The colonnade hotel

Boston, Massachusetts

United States

28 - 29 October, 2019

Event Speakers




Exhibitors Profile

Visitors Profile

This event is aimed at professionals in the pharmaceutical, biotech, medical device and venture capitalist fields responsible for:

•  M&;A/Licensing/Business Development
•  Corporate Strategy and Operations
•  R&D
•  Clinical Development
•  Legal/Transactions
•  Commercial
•  Finance
•  Regulatory


Event Partners